Scientists just published the most comprehensive review of GLP-1 medicines ever written.
It wasn't written by a journalist. It was written by the scientist who discovered GLP-1 in 1987.
What he found in 2026 will change how you think
about aging drugs forever.
Thread (1/12)
Sources for this thread:
- Drucker DJ. "The Expanding Landscape of GLP-1 Medicines." Nature Medicine 32:47–57 (2026)
DOI: 10.1038/s41591-025-04124-5
PMID: 41482564
https://t.co/0l0L8O0d8U
- Chao AM, Gilden A, Wadden TA. "GLP-1 Receptor Agonists for Obesity: Growing Popularity Met with Growing Questions over Safety."
PLOS Medicine 23(1):e1004871 (2026)
DOI: 10.1371/journal.pmed.1004871
PMID: 41533690
https://t.co/VHFWQihAZj
Athauda D et al. "The Promise of GLP-1 Receptor Agonists for Neurodegenerative Diseases." J Clin Invest 136(4):e194745 (2026)
https://t.co/nuKSA8ZcYS
Nature Aging GLP-1 + neurodegeneration Vol. 6:56–67 (2026) — abstract only
https://t.co/0UR0hwu8B6
Educational only. Not medical advice.
If this thread was useful:
→ RT post 1 to share with someone curious about GLP-1s
→ Follow for weekly peptide & longevity science breakdowns
→ Next thread: GLP-1 drugs & neurodegeneration — the full story
Educational only. Not medical advice. Always consult your physician.
Full sources below.
(12/12)